| Literature DB >> 14561169 |
George A DosReis1, Valeria M Borges.
Abstract
In the lung, inflammation followed by the loss of epithelial cell precursors beyond a safeguard threshold, leads to increased mesenchymal repair and autonomous fibrosis. Fas-Fas ligand induced apoptosis promotes IL-1beta secretion, neutrophil extravasation, and loss of epithelial cells. In models of lung disease, inflammation and fibrosis can be controlled by interfering with either Fas-Fas ligand interaction, or with downstream caspase activation. These results suggest that the Fas-Fas ligand pathway is a target for the design of new therapeutic strategies for lung diseases.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14561169 DOI: 10.2174/1568010033484287
Source DB: PubMed Journal: Curr Drug Targets Inflamm Allergy ISSN: 1568-010X